Yersinia infection induces glucose depletion and AMPK-dependent inhibition of pyroptosis in mice.
Journal
Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869
Informations de publication
Date de publication:
06 Jun 2024
06 Jun 2024
Historique:
received:
21
06
2023
accepted:
04
04
2024
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
6
6
2024
Statut:
aheadofprint
Résumé
Nutritional status and pyroptosis are important for host defence against infections. However, the molecular link that integrates nutrient sensing into pyroptosis during microbial infection is unclear. Here, using metabolic profiling, we found that Yersinia pseudotuberculosis infection results in a significant decrease in intracellular glucose levels in macrophages. This leads to activation of the glucose and energy sensor AMPK, which phosphorylates the essential kinase RIPK1 at S321 during caspase-8-mediated pyroptosis. This phosphorylation inhibits RIPK1 activation and thereby restrains pyroptosis. Boosting the AMPK-RIPK1 cascade by glucose deprivation, AMPK agonists, or RIPK1-S321E knockin suppresses pyroptosis, leading to increased susceptibility to Y. pseudotuberculosis infection in mice. Ablation of AMPK in macrophages or glucose supplementation in mice is protective against infection. Thus, we reveal a molecular link between glucose sensing and pyroptosis, and unveil a mechanism by which Y. pseudotuberculosis reduces glucose levels to impact host AMPK activation and limit host pyroptosis to facilitate infection.
Identifiants
pubmed: 38844594
doi: 10.1038/s41564-024-01734-6
pii: 10.1038/s41564-024-01734-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666–671 (2015).
pubmed: 26375259
doi: 10.1038/nature15541
He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25, 1285–1298 (2015).
pubmed: 26611636
pmcid: 4670995
doi: 10.1038/cr.2015.139
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
pubmed: 26375003
doi: 10.1038/nature15514
Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).
pubmed: 27281216
doi: 10.1038/nature18590
Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).
pubmed: 27383986
pmcid: 5539988
doi: 10.1038/nature18629
Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48, 35–44 e36 (2018).
pubmed: 29195811
doi: 10.1016/j.immuni.2017.11.013
Reddick, L. E. & Alto, N. M. Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol. Cell 54, 321–328 (2014).
pubmed: 24766896
pmcid: 4023866
doi: 10.1016/j.molcel.2014.03.010
Paquette, N. et al. Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl Acad. Sci. USA 109, 12710–12715 (2012).
pubmed: 22802624
pmcid: 3411953
doi: 10.1073/pnas.1008203109
Philip, N. H. et al. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-kappaB and MAPK signaling. Proc. Natl Acad. Sci. USA 111, 7385–7390 (2014).
pubmed: 24799700
pmcid: 4034241
doi: 10.1073/pnas.1403252111
Peterson, L. W. et al. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense. J. Exp. Med. 214, 3171–3182 (2017).
pubmed: 28855241
pmcid: 5679171
doi: 10.1084/jem.20170347
Sarhan, J. et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc. Natl Acad. Sci. USA 115, E10888–E10897 (2018).
pubmed: 30381458
pmcid: 6243247
doi: 10.1073/pnas.1809548115
Orning, P. et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science 362, 1064–1069 (2018).
pubmed: 30361383
pmcid: 6522129
doi: 10.1126/science.aau2818
Wickersham, M. et al. Metabolic stress drives keratinocyte defenses against Staphylococcus aureus infection. Cell Rep. 18, 2742–2751 (2017).
pubmed: 28297676
pmcid: 6799992
doi: 10.1016/j.celrep.2017.02.055
Zhang, Q. et al. AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity. Mol. Cell 82, 4519–4536.e7 (2022).
pubmed: 36384137
doi: 10.1016/j.molcel.2022.10.026
Tucey, T. M. et al. Glucose homeostasis is important for immune cell viability during Candida challenge and host survival of systemic fungal infection. Cell Metab. 27, 988–1006.e7 (2018).
pubmed: 29719235
pmcid: 6709535
doi: 10.1016/j.cmet.2018.03.019
Thaker, S. K. et al. Differential metabolic reprogramming by Zika virus promotes cell death in human versus mosquito cells. Cell Metab. 29, 1206–1216.e4 (2019).
pubmed: 30827860
pmcid: 6818653
doi: 10.1016/j.cmet.2019.01.024
Wang, A. et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell 166, 1512–1525.e2 (2016).
pubmed: 27610573
pmcid: 5555589
doi: 10.1016/j.cell.2016.07.026
Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251–262 (2012).
pubmed: 22436748
pmcid: 5726489
doi: 10.1038/nrm3311
Garcia, D. & Shaw, R. J. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell 66, 789–800 (2017).
pubmed: 28622524
pmcid: 5553560
doi: 10.1016/j.molcel.2017.05.032
Lin, S. C. & Hardie, D. G. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 27, 299–313 (2018).
pubmed: 29153408
doi: 10.1016/j.cmet.2017.10.009
Zhang, C. S. et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548, 112–116 (2017).
pubmed: 28723898
pmcid: 5544942
doi: 10.1038/nature23275
Zhang, C. S. et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20, 526–540 (2014).
pubmed: 25002183
doi: 10.1016/j.cmet.2014.06.014
Bhutta, M. S., Gallo, E. S. & Borenstein, R. Multifaceted role of AMPK in viral infections. Cells 10, 1118 (2021).
pubmed: 34066434
pmcid: 8148118
doi: 10.3390/cells10051118
Silwal, P., Kim, J. K., Yuk, J. M. & Jo, E. K. AMP-activated protein kinase and host defense against infection. Int. J. Mol. Sci. 19, 3495 (2018).
pubmed: 30404221
pmcid: 6274990
doi: 10.3390/ijms19113495
Jo, E. K., Silwal, P. & Yuk, J. M. AMPK-targeted effector networks in mycobacterial infection. Front. Microbiol. 10, 520 (2019).
pubmed: 30930886
pmcid: 6429987
doi: 10.3389/fmicb.2019.00520
Zhang, T. et al. Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. Science 380, 1372–1380 (2023).
pubmed: 37384704
pmcid: 10617018
doi: 10.1126/science.abn1725
Lachmandas, E. et al. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat. Microbiol. 2, 16246 (2016).
pubmed: 27991883
doi: 10.1038/nmicrobiol.2016.246
Galvan-Pena, S. & O’Neill, L. A. Metabolic reprograming in macrophage polarization. Front. Immunol. 5, 420 (2014).
pubmed: 25228902
pmcid: 4151090
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
pubmed: 28283069
pmcid: 5394987
doi: 10.1016/j.cell.2017.02.004
Battaglioni, S., Benjamin, D., Walchli, M., Maier, T. & Hall, M. N. mTOR substrate phosphorylation in growth control. Cell 185, 1814–1836 (2022).
pubmed: 35580586
doi: 10.1016/j.cell.2022.04.013
Sag, D., Carling, D., Stout, R. D. & Suttles, J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633–8641 (2008).
pubmed: 19050283
doi: 10.4049/jimmunol.181.12.8633
Zheng, Z. et al. The lysosomal rag-ragulator complex licenses RIPK1 and caspase-8-mediated pyroptosis by Yersinia. Science 372, eabg0269 (2021).
pubmed: 35058659
pmcid: 8769499
doi: 10.1126/science.abg0269
Calabrese, M. F. et al. Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms. Structure 22, 1161–1172 (2014).
pubmed: 25066137
doi: 10.1016/j.str.2014.06.009
Cool, B. et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403–416 (2006).
pubmed: 16753576
doi: 10.1016/j.cmet.2006.05.005
Lai, Y. C. et al. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem. J. 460, 363–375 (2014).
pubmed: 24665903
doi: 10.1042/BJ20131673
Muendlein, H. I. et al. ZBP1 promotes LPS-induced cell death and IL-1beta release via RHIM-mediated interactions with RIPK1. Nat. Commun. 12, 86 (2021).
pubmed: 33397971
pmcid: 7782486
doi: 10.1038/s41467-020-20357-z
Muendlein, H. I. et al. cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation. Science 367, 1379–1384 (2020).
pubmed: 32193329
pmcid: 7375259
doi: 10.1126/science.aay3878
Mounier, R. et al. AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 18, 251–264 (2013).
pubmed: 23931756
doi: 10.1016/j.cmet.2013.06.017
Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836–1849 (2015).
pubmed: 25801023
pmcid: 4494996
doi: 10.1016/j.celrep.2015.02.051
Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313–321 (2008).
pubmed: 18408713
pmcid: 5434866
doi: 10.1038/nchembio.83
Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227 (2012).
pubmed: 22265413
doi: 10.1016/j.cell.2011.11.031
Najjar, M. et al. RIPK1 and RIPK3 kinases promote cell-death-independent inflammation by Toll-like receptor 4. Immunity 45, 46–59 (2016).
pubmed: 27396959
pmcid: 4956514
doi: 10.1016/j.immuni.2016.06.007
Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268–31279 (2013).
pubmed: 24019532
pmcid: 3829437
doi: 10.1074/jbc.M113.462341
Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006).
pubmed: 16407890
doi: 10.1038/nature04515
Crute, B. E., Seefeld, K., Gamble, J., Kemp, B. E. & Witters, L. A. Functional domains of the α1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273, 35347–35354 (1998).
pubmed: 9857077
doi: 10.1074/jbc.273.52.35347
Hardie, D. G., Schaffer, B. E. & Brunet, A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 26, 190–201 (2016).
pubmed: 26616193
doi: 10.1016/j.tcb.2015.10.013
Geng, J. et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 8, 359 (2017).
pubmed: 28842570
pmcid: 5572456
doi: 10.1038/s41467-017-00406-w
Jaco, I. et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol. Cell 66, 698–710.e5 (2017).
pubmed: 28506461
pmcid: 5459754
doi: 10.1016/j.molcel.2017.05.003
Van den Bossche, J., O’Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 38, 395–406 (2017).
pubmed: 28396078
doi: 10.1016/j.it.2017.03.001
Kelly, B. & O’Neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771–784 (2015).
pubmed: 26045163
pmcid: 4493277
doi: 10.1038/cr.2015.68
Peterson, L. W. et al. Cell-extrinsic TNF collaborates with TRIF signaling to promote Yersinia-induced apoptosis. J. Immunol. 197, 4110–4117 (2016).
pubmed: 27733552
doi: 10.4049/jimmunol.1601294
Chu, X. et al. Gasdermin D-mediated pyroptosis is regulated by AMPK-mediated phosphorylation in tumor cells. Cell Death Dis. 14, 469 (2023).
pubmed: 37495617
pmcid: 10372026
doi: 10.1038/s41419-023-06013-6
Li, Y., Pu, D., Huang, J., Zhang, Y. & Yin, H. Protein phosphatase 1 regulates phosphorylation of gasdermin D and pyroptosis. Chem. Commun. 58, 11965–11968 (2022).
doi: 10.1039/D2CC03590A
Ai, Y. L. et al. Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. Cell Res. 33, 904–922 (2023).
pubmed: 37460805
pmcid: 10709431
doi: 10.1038/s41422-023-00848-6
Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 (2011).
pubmed: 21478880
pmcid: 4090391
doi: 10.1038/ni.2022
O’Neill, L. A., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors—redefining innate immunity. Nat. Rev. Immunol. 13, 453–460 (2013).
pubmed: 23681101
doi: 10.1038/nri3446
van den Berghe, G. et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345, 1359–1367 (2001).
pubmed: 11794168
doi: 10.1056/NEJMoa011300
NICE-SUGAR Study Investigators et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 360, 1283–1297 (2009).
doi: 10.1056/NEJMoa0810625
Zhou, Z. et al. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat. Commun. 13, 6656 (2022).
pubmed: 36333358
pmcid: 9636193
doi: 10.1038/s41467-022-34537-6
Shen, X. et al. Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics. Nat. Commun. 10, 1516 (2019).
pubmed: 30944337
pmcid: 6447530
doi: 10.1038/s41467-019-09550-x
Yang, Y. et al. Raw data for untargeted metabolomics. figshare https://doi.org/10.6084/m9.figshare.c.6888193.v1 (2024).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910
doi: 10.1038/nbt.1511